Codiak BioSciences (CDAK) Short Interest Ratio & Short Volume → Like Tiny Crypto Retirement Funds (From Crypto 101 Media) (Ad) Free CDAK Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisHeadlinesInsider TradesSocial MediaSustainabilityStock AnalysisHeadlinesInsider TradesSocial MediaSustainability Codiak BioSciences Short Interest DataCurrent Short Volume173,800 sharesPrevious Short Volume138,400 sharesChange Vs. Previous Month+25.58%Dollar Volume Sold Short$81,460.06Short Interest Ratio / Days to Cover1.0Last Record DateMarch 15, 2023Outstanding Shares36,830,000 sharesPercentage of Shares Shorted0.47%Today's Trading Volume0 sharesAverage Trading Volume1,366,845 sharesToday's Volume Vs. Average0% Short Selling Codiak BioSciences ? Sign up to receive the latest short interest report for Codiak BioSciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCDAK Short Interest Over TimeCDAK Days to Cover Over TimeCDAK Percentage of Float Shorted Over Time Ad Crypto 101 MediaLike Tiny Crypto Retirement FundsThe crypto bull market is about to blast off. Bitcoin and Ethereum are surging. But so are tiny altcoins that could be so profitable… They're like tiny crypto retirement funds. Click here and see how to get a copy. Codiak BioSciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/2023173,800 shares $81,460.06 +25.6%N/A1 $0.47 2/28/2023138,400 shares $66,432.00 -18.4%N/A0.7 $0.48 2/15/2023169,600 shares $111,291.52 -17.2%N/A0.9 $0.66 1/31/2023204,800 shares $145,408.00 +24.3%N/A1 $0.71 1/15/2023164,800 shares $99,209.60 -13.6%N/A0.8 $0.60 12/30/2022190,700 shares $75,822.32 -33.4%N/A0.9 $0.40 Get the Latest News and Ratings for CDAK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Codiak BioSciences and its competitors with MarketBeat's FREE daily newsletter. 12/15/2022286,400 shares $157,434.08 -22.7%N/A1.3 $0.55 11/30/2022370,600 shares $255,751.06 -2.5%N/A1.3 $0.69 11/15/2022380,200 shares $319,824.24 -40.2%N/A1.3 $0.84 10/31/2022635,800 shares $452,371.70 -13.9%N/A1.5 $0.71 10/15/2022738,600 shares $477,726.48 -11.4%N/A1.8 $0.65 9/30/2022834,000 shares $652,188.00 -8.5%N/A2.2 $0.78 9/15/2022911,500 shares $957,075.00 -37.6%N/A2.4 $1.05 8/31/20221,460,000 shares $3.14 million +47.0%9.6%5 $2.15 8/15/2022993,000 shares $2.44 million -12.1%6.5%3.4 $2.46 7/31/20221,130,000 shares $2.96 million -0.9%7.5%7.1 $2.62 7/15/20221,140,000 shares $3.21 million -20.3%7.5%6.9 $2.82 6/30/20221,430,000 shares $4.12 million -15.9%8.1%8.1 $2.88 6/15/20221,700,000 shares $4.90 million -1.7%11.2%10.4 $2.88 5/31/20221,730,000 shares $4.83 million -3.9%11.4%13 $2.79 5/15/20221,800,000 shares $4.66 million +4.1%11.9%13 $2.59 4/30/20221,730,000 shares $5.12 million +18.5%13.5%10.1 $2.96 4/15/20221,460,000 shares $5.93 million -5.2%11.4%8 $4.06 3/31/20221,540,000 shares $9.66 million +9.2%12.1%8.8 $6.27 3/15/20221,410,000 shares $6.87 million +4.4%11.0%8.2 $4.87 2/28/20221,350,000 shares $6.37 million +7.1%10.6%8.5 $4.72 2/15/20221,260,000 shares $6.48 million +52.6%9.9%8.4 $5.14 1/31/2022825,700 shares $5.47 million +32.9%6.6%8.5 $6.62 1/15/2022621,400 shares $5.67 million +15.3%N/A8.1 $9.13 12/31/2021539,000 shares $6.00 million -4.1%4.0%8.8 $11.14 12/15/2021562,200 shares $7.14 million +17.4%4.2%10.9 $12.70 11/30/2021478,900 shares $6.11 million -5.4%3.5%8.7 $12.75 11/15/2021506,000 shares $7.48 million -4.4%3.7%8.8 $14.79 10/29/2021529,500 shares $7.63 million -2.0%3.9%8 $14.41 10/15/2021540,300 shares $8.01 million +4.8%4.0%7.8 $14.82 9/30/2021515,800 shares $8.42 million +7.2%3.8%6.7 $16.33 9/15/2021481,100 shares $8.67 million -18.3%3.6%4.8 $18.03 8/31/2021588,500 shares $10.12 million -33.2%4.4%5.6 $17.20 8/13/2021881,100 shares $17.72 million -19.2%6.6%7.6 $20.11 7/30/20211,090,000 shares $18.86 million -6.8%8.1%9.1 $17.30Make This $3 Trade the Instant the Opening Bell Rings (Ad)Since the birth of Wall Street, one simple rule has remained the same.... Buy stocks that are cheap....When they’re on sale…. And when nobody else is looking…See Why This $3.00 Stock Could Hit $15.00 CDAK Short Interest - Frequently Asked Questions What is Codiak BioSciences' current short interest? Short interest is the volume of Codiak BioSciences shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 173,800 shares of CDAK short. Learn More on Codiak BioSciences' current short interest. What is a good short interest ratio for Codiak BioSciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CDAK shares currently have a short interest ratio of 1.0. Learn More on Codiak BioSciences's short interest ratio. Is Codiak BioSciences' short interest increasing or decreasing? Codiak BioSciences saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 173,800 shares, an increase of 25.6% from the previous total of 138,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Codiak BioSciences' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Codiak BioSciences: Bruush Oral Care Inc. (101.16%), Panbela Therapeutics, Inc. (2.36%), Scinai Immunotherapeutics Ltd. (0.45%), TC Biopharm (Holdings) Plc (28.97%), Eloxx Pharmaceuticals, Inc. (1.49%), Palisade Bio, Inc. (0.85%), Avalon GloboCare Corp. (6.88%), Finch Therapeutics Group, Inc. (0.45%), NanoString Technologies, Inc. (12.55%), Fresh Tracks Therapeutics, Inc. (0.17%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($3.66 billion), Occidental Petroleum Co. ($2.62 billion), Coinbase Global, Inc. ($2.38 billion), T. Rowe Price Group, Inc. ($2.13 billion), Verisk Analytics, Inc. ($2.08 billion), Snowflake Inc. ($1.95 billion), Paramount Global ($1.78 billion), Etsy, Inc. ($1.60 billion), Teck Resources Limited ($1.51 billion), and Voya Financial, Inc. ($1.49 billion). View all of the most shorted stocks. What does it mean to sell short Codiak BioSciences stock? Short selling CDAK is an investing strategy that aims to generate trading profit from Codiak BioSciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Codiak BioSciences? A short squeeze for Codiak BioSciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CDAK, which in turn drives the price of the stock up even further. How often is Codiak BioSciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CDAK, twice per month. The most recent reporting period available is March, 15 2023. More Short Interest Resources from MarketBeat Related Companies: Bruush Oral Care Short Interest Panbela Therapeutics Short Interest Scinai Immunotherapeutics Short Interest TC Biopharm Short Interest Eloxx Pharmaceuticals Short Interest Palisade Bio Short Interest Avalon GloboCare Short Interest Finch Therapeutics Group Short Interest NanoString Technologies Short Interest Fresh Tracks Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CDAK) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceStock-Picking AI Predicts #1 Stock of 2024AltimetryDid you make $29,000 two days with AI options trades?Prosper Trading AcademyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThe world’s greatest investmentPorter & Company